Opioid tolerance impacts compliance with enhanced recovery pathway after major abdominal surgery

Oluwafemi P. Owodunni, Mohammad H. Zaman, Mehrnaz Ighani, Michael C. Grant, Dianne Bettick, Sara Sateri, Thomas Magnuson, Susan L Gearhart

Research output: Contribution to journalArticle

Abstract

Background: Opioid tolerant patients have been shown to have poor postoperative outcomes. Enhanced recovery pathways are evidence-based interventions that focus on optimizing recovery, and their effectiveness depends on the degree of compliance with the pathway. We wish to determine pathway compliance and its impact on postoperative outcomes in opioid tolerant patients undergoing abdominal surgery on an enhanced recovery pathway. Methods: From December 2014 to June 2017, 646 patients undergoing major abdominal surgery on an enhanced recovery pathway were included. Patients <18 years and having emergency surgery were excluded. Compliance was measured to 14 perioperative pathway standards and high-compliance was defined as adhering to ≥75% standards. Opioid tolerance was defined as any patient taking a prescribed opioid medication equivalent to 60 mg of oral morphine per day for 1 week prior to surgery. The Colorectal Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity was used for risk-adjusted analyses. Outcomes of interest include length of stay, major complications (Clavien-Dindo ≥2), 30-day readmission rates, and mortality. Results: Overall, 114 (18%) patients were opioid tolerant and 532 (82%) were not opioid tolerant. Opioid tolerant patients were less likely to be highly compliant with enhanced recovery pathway standards than non-tolerant patients (35% vs 54%; P < .001); particularly postoperative care standards. On adjusted analysis, opioid tolerance was associated with a 2-fold increase in readmissions following major abdominal surgery. Examining only those patients with opioid tolerance, adjusted analysis demonstrated that high compliance with the enhanced recovery pathway standards was independently associated with a 26% reduction in length of stay, over a 90% reduction in major complications, and mitigated the effect on readmissions. Conclusion: The authors provide evidence that opioid tolerance is associated with less favorable outcomes in patients undergoing major abdominal surgery on an enhanced recovery pathway, and this is likely due to a lack of pathway compliance. Establishing strategies to improve compliance in this challenging patient cohort may serve to mitigate the negative impact of opioid tolerance.

Original languageEnglish (US)
JournalSurgery (United States)
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Opioid Analgesics
Compliance
Length of Stay
Mortality
Postoperative Care
Standard of Care
Morphine
Emergencies
Morbidity

ASJC Scopus subject areas

  • Surgery

Cite this

Opioid tolerance impacts compliance with enhanced recovery pathway after major abdominal surgery. / Owodunni, Oluwafemi P.; Zaman, Mohammad H.; Ighani, Mehrnaz; Grant, Michael C.; Bettick, Dianne; Sateri, Sara; Magnuson, Thomas; Gearhart, Susan L.

In: Surgery (United States), 01.01.2019.

Research output: Contribution to journalArticle

Owodunni, Oluwafemi P. ; Zaman, Mohammad H. ; Ighani, Mehrnaz ; Grant, Michael C. ; Bettick, Dianne ; Sateri, Sara ; Magnuson, Thomas ; Gearhart, Susan L. / Opioid tolerance impacts compliance with enhanced recovery pathway after major abdominal surgery. In: Surgery (United States). 2019.
@article{2d0b742565b84deaa0b832940c9238b0,
title = "Opioid tolerance impacts compliance with enhanced recovery pathway after major abdominal surgery",
abstract = "Background: Opioid tolerant patients have been shown to have poor postoperative outcomes. Enhanced recovery pathways are evidence-based interventions that focus on optimizing recovery, and their effectiveness depends on the degree of compliance with the pathway. We wish to determine pathway compliance and its impact on postoperative outcomes in opioid tolerant patients undergoing abdominal surgery on an enhanced recovery pathway. Methods: From December 2014 to June 2017, 646 patients undergoing major abdominal surgery on an enhanced recovery pathway were included. Patients <18 years and having emergency surgery were excluded. Compliance was measured to 14 perioperative pathway standards and high-compliance was defined as adhering to ≥75{\%} standards. Opioid tolerance was defined as any patient taking a prescribed opioid medication equivalent to 60 mg of oral morphine per day for 1 week prior to surgery. The Colorectal Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity was used for risk-adjusted analyses. Outcomes of interest include length of stay, major complications (Clavien-Dindo ≥2), 30-day readmission rates, and mortality. Results: Overall, 114 (18{\%}) patients were opioid tolerant and 532 (82{\%}) were not opioid tolerant. Opioid tolerant patients were less likely to be highly compliant with enhanced recovery pathway standards than non-tolerant patients (35{\%} vs 54{\%}; P < .001); particularly postoperative care standards. On adjusted analysis, opioid tolerance was associated with a 2-fold increase in readmissions following major abdominal surgery. Examining only those patients with opioid tolerance, adjusted analysis demonstrated that high compliance with the enhanced recovery pathway standards was independently associated with a 26{\%} reduction in length of stay, over a 90{\%} reduction in major complications, and mitigated the effect on readmissions. Conclusion: The authors provide evidence that opioid tolerance is associated with less favorable outcomes in patients undergoing major abdominal surgery on an enhanced recovery pathway, and this is likely due to a lack of pathway compliance. Establishing strategies to improve compliance in this challenging patient cohort may serve to mitigate the negative impact of opioid tolerance.",
author = "Owodunni, {Oluwafemi P.} and Zaman, {Mohammad H.} and Mehrnaz Ighani and Grant, {Michael C.} and Dianne Bettick and Sara Sateri and Thomas Magnuson and Gearhart, {Susan L}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.surg.2019.08.001",
language = "English (US)",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Opioid tolerance impacts compliance with enhanced recovery pathway after major abdominal surgery

AU - Owodunni, Oluwafemi P.

AU - Zaman, Mohammad H.

AU - Ighani, Mehrnaz

AU - Grant, Michael C.

AU - Bettick, Dianne

AU - Sateri, Sara

AU - Magnuson, Thomas

AU - Gearhart, Susan L

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Opioid tolerant patients have been shown to have poor postoperative outcomes. Enhanced recovery pathways are evidence-based interventions that focus on optimizing recovery, and their effectiveness depends on the degree of compliance with the pathway. We wish to determine pathway compliance and its impact on postoperative outcomes in opioid tolerant patients undergoing abdominal surgery on an enhanced recovery pathway. Methods: From December 2014 to June 2017, 646 patients undergoing major abdominal surgery on an enhanced recovery pathway were included. Patients <18 years and having emergency surgery were excluded. Compliance was measured to 14 perioperative pathway standards and high-compliance was defined as adhering to ≥75% standards. Opioid tolerance was defined as any patient taking a prescribed opioid medication equivalent to 60 mg of oral morphine per day for 1 week prior to surgery. The Colorectal Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity was used for risk-adjusted analyses. Outcomes of interest include length of stay, major complications (Clavien-Dindo ≥2), 30-day readmission rates, and mortality. Results: Overall, 114 (18%) patients were opioid tolerant and 532 (82%) were not opioid tolerant. Opioid tolerant patients were less likely to be highly compliant with enhanced recovery pathway standards than non-tolerant patients (35% vs 54%; P < .001); particularly postoperative care standards. On adjusted analysis, opioid tolerance was associated with a 2-fold increase in readmissions following major abdominal surgery. Examining only those patients with opioid tolerance, adjusted analysis demonstrated that high compliance with the enhanced recovery pathway standards was independently associated with a 26% reduction in length of stay, over a 90% reduction in major complications, and mitigated the effect on readmissions. Conclusion: The authors provide evidence that opioid tolerance is associated with less favorable outcomes in patients undergoing major abdominal surgery on an enhanced recovery pathway, and this is likely due to a lack of pathway compliance. Establishing strategies to improve compliance in this challenging patient cohort may serve to mitigate the negative impact of opioid tolerance.

AB - Background: Opioid tolerant patients have been shown to have poor postoperative outcomes. Enhanced recovery pathways are evidence-based interventions that focus on optimizing recovery, and their effectiveness depends on the degree of compliance with the pathway. We wish to determine pathway compliance and its impact on postoperative outcomes in opioid tolerant patients undergoing abdominal surgery on an enhanced recovery pathway. Methods: From December 2014 to June 2017, 646 patients undergoing major abdominal surgery on an enhanced recovery pathway were included. Patients <18 years and having emergency surgery were excluded. Compliance was measured to 14 perioperative pathway standards and high-compliance was defined as adhering to ≥75% standards. Opioid tolerance was defined as any patient taking a prescribed opioid medication equivalent to 60 mg of oral morphine per day for 1 week prior to surgery. The Colorectal Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity was used for risk-adjusted analyses. Outcomes of interest include length of stay, major complications (Clavien-Dindo ≥2), 30-day readmission rates, and mortality. Results: Overall, 114 (18%) patients were opioid tolerant and 532 (82%) were not opioid tolerant. Opioid tolerant patients were less likely to be highly compliant with enhanced recovery pathway standards than non-tolerant patients (35% vs 54%; P < .001); particularly postoperative care standards. On adjusted analysis, opioid tolerance was associated with a 2-fold increase in readmissions following major abdominal surgery. Examining only those patients with opioid tolerance, adjusted analysis demonstrated that high compliance with the enhanced recovery pathway standards was independently associated with a 26% reduction in length of stay, over a 90% reduction in major complications, and mitigated the effect on readmissions. Conclusion: The authors provide evidence that opioid tolerance is associated with less favorable outcomes in patients undergoing major abdominal surgery on an enhanced recovery pathway, and this is likely due to a lack of pathway compliance. Establishing strategies to improve compliance in this challenging patient cohort may serve to mitigate the negative impact of opioid tolerance.

UR - http://www.scopus.com/inward/record.url?scp=85072089193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072089193&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2019.08.001

DO - 10.1016/j.surg.2019.08.001

M3 - Article

JO - Surgery

JF - Surgery

SN - 0039-6060

ER -